Does USTEKINUMAB Cause Bone erosion? 648 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 648 reports of Bone erosion have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.8% of all adverse event reports for USTEKINUMAB.
648
Reports of Bone erosion with USTEKINUMAB
0.8%
of all USTEKINUMAB reports
399
Deaths
321
Hospitalizations
How Dangerous Is Bone erosion From USTEKINUMAB?
Of the 648 reports, 399 (61.6%) resulted in death, 321 (49.5%) required hospitalization, and 314 (48.5%) were considered life-threatening.
Is Bone erosion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 648 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Bone erosion?
METHOTREXATE (1,713)
ADALIMUMAB (1,640)
ETANERCEPT (1,474)
TOCILIZUMAB (1,374)
LEFLUNOMIDE (1,291)
ABATACEPT (1,264)
HYDROXYCHLOROQUINE (1,138)
RITUXIMAB (1,064)
SULFASALAZINE (1,042)
INFLIXIMAB (1,040)
Which USTEKINUMAB Alternatives Have Lower Bone erosion Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE